telephone:+7 (8352) 222-490
Mail:info@interactive-plus.ru
rus eng


  1. Main
  2. Journal "Interactive science"
  3. No 9 (19)
  4. Psychoactive effects and toxic reactions associate...
Центр научного сотрудничества "Интерактив плюс"
info@interactive-plus.ru
+7 (8352) 222-490
2130122532
Центр научного сотрудничества «Интерактив плюс»
RU
428000
Чувашская Республика
г.Чебоксары
ул.Гражданская, д.75
428000, Россия, Чувашская Республика, г. Чебоксары, улица Гражданская, дом 75
+7 (8352) 222-490
RU
428000
Чувашская Республика
г.Чебоксары
ул.Гражданская, д.75
56.125001
47.208966

Psychoactive effects and toxic reactions associated with the use of mephedrone and methylone (review)

Research Article
DOI: 10.21661/r-463419
Open Access
Monthly international academic journal «Interactive science»
Creative commons logo
Published in:
Monthly international academic journal «Interactive science»
Authors:
Antsyborov A.V. 1 , Asadulin A.R. 2
Work direction:
Медицина
Rating:
Article accesses:
6660
Published in:
doaj
eLibrary.ru
КиберЛенинка
1 Mental Health Clinic «Psyche»
2 FSBEI HE "Bashkir State Medical University" of the Ministry of Healthcare of the Russian Federation
For citation:
Antsyborov A. V., & Asadulin A. R. (2017). Psychoactive effects and toxic reactions associated with the use of mephedrone and methylone (review). Interactive science, 24-31. https://doi.org/10.21661/r-463419
  • Metadata
  • Full text
  • Reviewing
  • Metrics
  • Related articles
UDC 61

Abstract

One of the most common classes among new psychoactive substances are substituted cathinones. The most popular substances among consumers, representatives of this class, are mephedrone and methylone. In this review, the accumulated scientific data on clinical effects, side effects, mechanisms of action associated with the use of methylone and mephedrone are systematized. When writing the review, two representative databases were used to find the scientific sources of PubMed and Google Scholar. The authors also used data from the site Erowid Center (non-profit educational organization in the United States, which provides information on psychoactive plants and chemicals). The literature search was conducted between 2005 and 2015.

References

  1. 1. Adamowicz, P., et al., The prevalence of new psychoactive substances in biological material – a three-year review of casework in Poland // J. Drug Test Anal. – 2016. – Vol. 8. – P. 64–71.
  2. 2. Bajaj, N., Mullen, D., Wylie, S., Dependence and psychosis with 4-methylmethcathinone (mephedrone) use // J. BMJ Case Rep. – 2010. – Vol. 116. – P. 72–78.
  3. 3. Barrios, L., et al., Death following ingestion of methylone // J. Int J Legal Med. – 2015. – Vol. 83. – P. 112–119.
  4. 4. Bossong, M.G., Van Dijk, J.P., Niesink, R.J., Methylone and mCPP, two new drugs of abuse? // J. Addict Biol. – 2005. – Vol. 10. – P. 321–3.
  5. 5. Boulanger-Gobeil, C., et al., Seizures and hyponatremia related to ethcathinone and methylone poisoning // J. Med Toxicol. – 2012. – Vol. 8. – P. 59–61.
  6. 6. Bourne, A., et al., «Chemsex» and harm reduction need among gay men in South London // J. Int J Drug Policy. – 2015. – Vol. 26. – P. 1171–6.
  7. 7. Brunt, T.M., et al., Instability of the ecstasy market and a new kid on the block: mephedrone // J. Psychopharmacol. – 2011. – Vol. 25. – P. 1543–7.
  8. 8. Busardo, F.P., et al., Mephedrone related fatalities: a review // J. Eur Rev Med Pharmacol Sci. – 2015. – Vol. 19. – P. 3777–90.
  9. 9. Carbone, P.N., et al., Sudden cardiac death associated with methylone use // J. Am J Forensic Med Pathol. – 2013. – Vol. 34. – P. 26–8.
  10. 10. Carhart-Harris, R.L., King, L.A., Nutt, D.J., A web-based survey on mephedrone // J. Drug Alcohol Depend. – 2011. – Vol. 118. – P. 19–22.
  11. 11. Chan, W.L., Wood, D.M., Dargan, P.I., Significant Misuse of Sildenafil in London Nightclubs // J. Subst Use Misuse. – 2015. – Vol. 50. – P. 1390–4.
  12. 12. Conway, N., et al., Urinary retention secondary to mephedrone // J. BMJ Case Rep. – 2013.
  13. 13. Cottencin, O., Rolland, B., Karila, L., New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature // J. Curr Pharm Des. 2014. – Vol. 20. – P. 4106–11.
  14. 14. De Felice, L.J., Glennon, R.A., Negus, S.S., Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology // J. Life Sci. – 2014. – Vol. 97. – P. 20–6.
  15. 15. Debruyne, D., et al., Mephedrone: a designer drug of recent use in France // J. Therapie. – 2010. – Vol. 65. – P. 519–24.
  16. 16. DoJ., D.E.A., Schedules of controlled substances: temporary placement of three synthetic cathinones in schedule I. Final order // J. Fed Regist. – 2011. – Vol. 76. – P. 65371–5.
  17. 17. Dragogna, F., et al., A case of severe psychosis induced by novel recreational drugs // J. F1000Res. – 2014. – Vol. 3. – P. 21.
  18. 18. Drummond, A., et al., Study on the prevalence of drug use, including intravenous drug use, and blood-borne viruses among the Irish prisoner population // National Advisory Committee on Drugs and Alcohol. – Dublin., 2014. – P. 38–41.
  19. 19. EMCDDA, EMCDDA and Europol step up information collection on mephedrone. – 2010a. – P. 11–89.
  20. 20. EMCDDA, EMCDDA-Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA-2010b. – P. 9–94.
  21. 21. EMCDDA, Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone)In accordance with Article 6 of Council Decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances. – 2010c. – P. 7–96.
  22. 22. EMCDDA, European Monitoring Center for Drugs and Drug Abuse: Annual report 2011: The state of the drug problem in Europe. – 2012a. – P. 3–59.
  23. 23. EMCDDA, Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012). – 2012b. – P. 6–75.
  24. 24. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction European Drug Report 2014: Trends and developments. Luxembourg: Publications Office of the. – 2014. – P. 8–79.
  25. 25. German, C.L., Fleckenstein, A.E., Hanson, G.R., Bath salts and synthetic cathinones: an emerging designer drug phenomenon // J. Life Sci. – 2014. – Vol. 97. – P. 2–8.
  26. 26. Glennon, R.A., Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention // J. Adv Pharmacol. – 2014. – Vol. 69. – P. 581–620.
  27. 27. Graham, R., Bowen, N., Singh, J., Mephedrone inhalation causes pneumomediastinum // J. BMJ Case Rep. – 2014. – Vol. 12. – P. 34–39.
  28. 28. Green, A.R., et al., The preclinical pharmacology of mephedrone; not just MDMA by another name // J. Br J Pharmacol. – 2014. – Vol. 171. – P. 2251–68.
  29. 29. Gustavsson, D., Escher, C., Mephedrone--Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance // J. Lakartidningen. – 2009. – Vol. 106. – P. 2769–71
  30. 30. Jacob, P., Shulgin, A., inventors, Neurobiological Technologies, Inc., assignee. Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents // US Patent WO9639133.1996, June 6.
  31. 31. John, M.E., Thomas-Rozea, C., Hahn, D., Bath Salts Abuse leading to New Onset Psychosis and Potential for Violence // J. Clin Schizophr Relat Psychoses. – 2014. – Vol. 11. – P. 120–124.
  32. 32. Kapitany-Foveny, M., et al., Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone? // J. Hum Psychopharmacol. – 2015. – Vol. 30. – P. 233–43.
  33. 33. Karila, L., Reynaud, M., Mephedrone: A designer drug legally available on the Web. //J. Presse Med. – 2010. – Vol. 39. – P. 834–5.
  34. 34. Karila, L., Reynaud, M., GHB and synthetic cathinones: clinical effects and potential consequences // J. Drug Test Anal. – 2011. – Vol. 3. – P. 552–9.
  35. 35. Karila, L., et al., Synthetic cathinones: a new public health problem // J. Curr Neuropharmacol. – 2015. – Vol. 13. – P. 12–20.
  36. 36. Kelly, J.P., Cathinone derivatives: a review of their chemistry, pharmacology and toxicology // J. Drug Test Anal. – 2011. – Vol. 3. – P. 439–53.
  37. 37. Martinotti, G., et al., Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas // J. Hum Psychopharmacol. – 2015. – Vol. 30. – P. 295–301.
  38. 38. McCall, H., et al., What is chemsex and why does it matter? // J.BMJ. – 2015. – Vol. 351. – h. 5790.
  39. 39. McIntyre, I.M., et al., Acute methylone intoxication in an accidental drowning a case report // J. Forensic Sci Int. – 2013. – Vol. 231. – P. 1–3.
  40. 40. McNamara, S., Stokes, S., Coleman, N., Head shop compound abuse amongst attendees of the Drug Treatment Centre Board // J. Int Med. – 2010. – Vol. 103. – P. 134–137.
  41. 41. Meyer, M.R., Maurer, H.H., Metabolism of designer drugs of abuse: an updated review // J. Curr Drug Metab. – 2010. – Vol. 11. – P. 468–82.
  42. 42. Meyer, M.R., et al., Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry // J. Anal Bioanal Chem. – 2010. – Vol. 397. – P. 1225–33.
  43. 43. Morris, H., Mephedrone: the phantom menace // J. Vice. – 2010. – Vol. 98. – P. 100.
  44. 44. Pearson, J.M., et al., Three fatal intoxications due to methylone // J. Anal Toxicol. – 2012. – Vol. 36. – P. 444–51.
  45. 45. Piao, Y., et al., Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters // Behav Pharmacol. – 2015. – Vol. 26. – P. 345–52.
  46. 46. Prosser, J.M., Nelson, L.S., The toxicology of bath salts: a review of synthetic cathinones // J Med Toxicol. – 2012. – Vol. 8. – P. 33–42.
  47. 47. Rosenbaum, C.D., Carreiro, S.P., Babu, K.M., Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines // J Med Toxicol. – 2012. – Vol. 8. – P. 15–32.
  48. 48. Rust, K.Y., et al., Prevalence of new psychoactive substances: A retrospective study in hair // J. Drug Test Anal. – 2012. – Vol. 4. – P. 402–8.
  49. 49. Sanchez, S., Sur un homologue de l'ephedrine // J. Bull Soc Chim Fr. – 1929. – Vol. 45. – P. 284–6.
  50. 50. Schifano, F., et al., Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues // J. Psychopharmacology (Berl). – 2011. – Vol. 214. – P. 593–602.
  51. 51. Schifano, F., Corkery, J., Ghodse, A., Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, «meow meow») in the United Kingdom // J. Clin Psychopharmacol. – 2012. – Vol. 32. – P. 710–4.
  52. 52. Shimizu, E., et al., Combined intoxication with methylone and 5-MeO-MIPT. // J. Prog Neuropsychopharmacol Biol Psychiatry. – 2007. – Vol. 31. – P. 288–91.
  53. 53. Simmler, L.D., et al., Pharmacological characterization of designer cathinones in vitro. // J. Br J Pharmacol. – 2013. – Vol. – 168. – P. 458–70.
  54. 54. U.S., Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System: Midyear Report 2012. U.S. Drug Enforcement Administration. – Springfield, VA, 2013. – P. 9–54.
  55. 55. US Drug Enforcement Administration, US Drug Enforcement Administration Office of Diversion Control. National Forensic Laboratory Information System: year 2011 annual report. In: Administration USDE, editor. – Springfield, VA. – 2012. – P. 4–78.
  56. 56. US Drug Enforcement Administration, US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System: Year 2014 Annual Report. – Springfield, VA: US Drug Enforcement Administration, 2015. – P. 5–68.
  57. 57. Van Hout, M.C., Bingham, T., «A costly turn on»: patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors // J. Int J Drug Policy. – 2012. – Vol. 23. – P. 188–97.
  58. 58. Vardakou, I., Pistos, C., Spiliopoulou, C., Drugs for youth via Internet and the example of mephedrone // J. Toxicol Lett. – 2011. – Vol. 201. – P. 191–5.
  59. 59. Warrick, B.J., et al., Lethal serotonin syndrome after methylone and butylone ingestion // J. Med Toxicol. – 2012. – Vol. – 8. – P. 65–8.
  60. 60. Weaver, M.F., Hopper, J.A., Gunderson, E.W., Designer drugs 2015: assessment and management // J. Addict Sci Clin Pract. – 2015. – Vol. 10. – P. 8.
  61. 61. WHO, 2014. Methylone (bk-MDMA) – Critical Review Report – Expert Committee on Drug Dependence Thirty-sixth Meeting. – Geneva, 16–20 June 2014.
  62. 62. Winder, G.S., Stern, N., Hosanagar, A., Are «bath salts» the next generation of stimulant abuse? // J. Subst Abuse Treat. – 2013. Vol. 44. – P. 42–5.
  63. 63. Winstock, A.R., et al., Mephedrone, new kid for the chop? // J. Addiction. –2011. – Vol. 106. – P. 154–61.
  64. 64. Wood, D., et al., Limited use of novel psychoactive substances in South London nightclubs // J. QJM. – 2012. – Vol. 105. – P. 959–64.
  65. 65. Wood, D.M., Greene, S.L., Dargan, P.I., Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone // J. Emerg Med. – 2011. – Vol. 28. – P. 280–2.
  66. 66. Wood, D.M., Dargan, P.I., Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity // J. Prog Neuropsychopharmacol Biol Psychiatry. – 2012. – Vol. 39. – P. 227–33.
  67. 67. Zawilska, J.B., Wojcieszak, J., Designer cathinones-an emerging class of novel recreational drugs // J. Forensic Sci Int. – 2013. – Vol. 231. – P. 42–53.

Comments(0)

When adding a comment stipulate:
  • the relevance of the published material;
  • general estimation (originality and relevance of the topic, completeness, depth, comprehensiveness of topic disclosure, consistency, coherence, evidence, structural ordering, nature and the accuracy of the examples, illustrative material, the credibility of the conclusions;
  • disadvantages, shortcomings;
  • questions and wishes to author.